Annika Janefeldt

The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models

Stephen T. Durant, Li Zheng, Yingchun Wang et al. · Science Advances · 2018 · 292 citations · Full text

Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs

Nicola Colclough, Kan Chen, Peter Johnström et al. · Clinical Cancer Research · 2020 · 215 citations · Full text

The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids

Sebastian Prill, Andrea Caddeo, Guido Baselli et al. · Scientific Reports · 2019 · 109 citations · Full text

Genetics, Genetic Epidemiology, Pathology +20

Determination of Human Hepatocyte Intrinsic Clearance for Slowly Metabolized Compounds: Comparison of a Primary Hepatocyte/Stromal Cell Co-culture with Plated Primary Hepatocytes and HepaRG

Britta Bonn, Petter Svanberg, Annika Janefeldt et al. · Drug Metabolism and Disposition · 2016 · 89 citations

Structural and functional characterization of a specific antidote for ticagrelor

Andrew Buchanan, Philip M. Newton, S. KENNETH PEHRSSON et al. · Blood · 2015 · 88 citations · Full text